KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
$1,399,972N01FY2022DANIH
The Emmes Company, Llc, Rockville MD
Investigators
Abstract
Substance Misuse
View original record on NIH RePORTER →